Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Enhanced mGluR1 function causes motor deficits and region-specific Purkinje cell dysfunction.

Ibrahim MF., Boyanova S., Cheng YC., Ligneul C., Bains RS., Johnpulle TC., Lerch JP., Mann EO., Oliver PL., Becker EBE.

Spinocerebellar ataxias (SCAs) are autosomal dominantly inherited neurodegenerative disorders with no effective treatment. Aberrant signalling through the metabotropic glutamate receptor (mGluR1) has been implicated in several SCAs. However, whether disease is caused through decreased or increased mGluR1 signalling remains controversial. Here, we generate the first mouse model of enhanced mGluR1 function by introducing a gain-of-function mutation (p.Y792C) that causes SCA44 in the metabotropic glutamate receptor 1 (Grm1) gene. Grm1 mutant mice recapitulate key pathophysiological aspects of SCA, including progressive motor deficits, altered climbing fibre innervation and perturbed Purkinje cell (PC) spontaneous activity. We report that changes in synaptic innervation and intrinsic PC activity upon overactive mGluR1 signalling manifest in a lobule- and disease-stage-specific manner. Our findings demonstrate that enhanced mGluR1 function is a direct and specific driver of PC dysfunction and pathology and provide a mechanism for understanding the selective vulnerability of different PC populations in SCA.